Rodgers & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,020
Closed -$241K 92
2023
Q4
$241K Hold
3,020
0.03% 79
2023
Q3
$215K Hold
3,020
0.03% 83
2023
Q2
$233K Hold
3,020
0.03% 77
2023
Q1
$227K Hold
3,020
0.04% 77
2022
Q4
$238K Hold
3,020
0.04% 76
2022
Q3
$212K Hold
3,020
0.04% 78
2022
Q2
$242K Hold
3,020
0.04% 79
2022
Q1
$229K Sell
3,020
-600
-17% -$47.5K 0.04% 87
2021
Q4
$309K Hold
3,620
0.05% 77
2021
Q3
$274K Sell
3,620
-180
-5% -$14.3K 0.04% 77
2021
Q2
$309K Hold
3,800
0.05% 72
2021
Q1
$300K Hold
3,800
0.05% 73
2020
Q4
$325K Buy
+3,800
New +$314K 0.06% 72

Other funds holding CL

Rodgers & Associates's CL Position: Q1 2024 in Review

Rodgers & Associates sold out of Colgate-Palmolive (CL) in Q1 2024, closing a stake of 3,020 shares — an estimated $241K sold.

Rodgers & Associates first reported a position in CL in Q4 2020 and held it in 13 quarters. The position peaked at $325K in Q4 2020. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.

  • Rodgers & Associates reported no remaining Colgate-Palmolive position as of Q1 2024 after selling out during the quarter.
  • Rodgers & Associates sold 3,020 Colgate-Palmolive shares in Q1 2024, an estimated $241K.
  • Rodgers & Associates first reported a position in Colgate-Palmolive in Q4 2020 and held it in 13 quarters.
  • Rodgers & Associates's Colgate-Palmolive position peaked at $325K in Q4 2020.
  • 1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Rodgers & Associates's 13F filing for Q1 2024, filed 10 May 2024.